Clinical trial for Multiple Myeloma
Official title A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
ClinicalTrials.gov ID: NCT06892522
What this study is testing
What is Etentamig?
Etentamig is an investigational intravenous infusion being studied as a potential treatment for multiple myeloma.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether the investigational drugs Etentamig and ABBV‑2001 are safe and work for people with multiple myeloma. It also looks at how the drugs move through the body.
- Who it's for
- You may be able to join if you are an adult with multiple myeloma that has come back or did not improve with other treatments.
- What's involved
- You would receive injections of the study drugs, sometimes with other medicines. You will have regular hospital or clinic visits for blood tests, health checks, and questionnaires.
- Time commitment
- The study lasts about 10 years and requires many visits over that time.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eastern cooperative oncology group (ECOG) performance of \<= 1.
- Confirmed diagnosis of multiple myeloma (MM) according to the International Myeloma Working Group (IMWG) diagnostic criteria with either newly...
You likely can't join if
- Participant who has known active central nervous system involvement of MM.
- Participant who has known active infection as outlined in the protocol.
The study team makes the final eligibility decision.
Where it is enrolling
- Duarte, California, United States
- Irvine, California, United States
- San Francisco, California, United States
- Denver, Colorado, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- New York, New York, United States
- Chapel Hill, North Carolina, United States
- Charlotte, North Carolina, United States
- Winston-Salem, North Carolina, United States
- Cincinnati, Ohio, United States
- Columbus, Ohio, United States
- Dallas, Texas, United States
- Salt Lake City, Utah, United States
- Coffs Harbour, New South Wales, Australia
- Port Macquarie, New South Wales, Australia
- Westmead, New South Wales, Australia
- South Brisbane, Queensland, Australia
- Adelaide, South Australia, Australia
- Fitzroy, Victoria, Australia
+ 15 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Duarte, California, United States; Irvine, California, United States; San Francisco, California, United States; Denver, Colorado, United States; Tampa, Florida, United States; Atlanta, Georgia, United States and 29 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.